Department of Radiation Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, 111 S 11 ST, Suite G301, Philadelphia, PA, 19107, USA.
The College of New Jersey, Ewing, NJ, USA.
J Med Case Rep. 2023 Mar 20;17(1):102. doi: 10.1186/s13256-023-03812-5.
Hemangioblastoma of the central nervous system is an uncommon benign neoplasm, with about 25% of cases in patients with von Hippel-Lindau disease. The incidence of metastasis is rare, particularly in patients without von Hippel-Lindau disease. We report a case of hemangioblastoma with leptomeningeal dissemination as a late recurrence.
A 65-year-old Caucasian man with a history of World Health Organization grade I hemangioblastoma of the cerebellar vermis underwent gross total resection in 1997. In early 2018, he developed intracranial recurrences with diffuse leptomeningeal disease of the entire spine. The patient underwent resection of intracranial recurrence, followed by palliative craniospinal irradiation. The disease progressed quickly, and he died 8 months after recurrence.
Despite a benign pathology, hemangioblastoma has a low risk of metastasis. The outcome for hemangioblastoma patients with metastasis is poor. Multidisciplinary care for patients with metastatic hemangioblastoma warrants further investigation, and an effective systemic option is urgently needed. Regular lifelong follow-up of at-risk patients is recommended.
中枢神经系统血管母细胞瘤是一种罕见的良性肿瘤,约有 25%的病例发生在 von Hippel-Lindau 病患者中。转移的发生率罕见,特别是在没有 von Hippel-Lindau 病的患者中。我们报告了一例脑膜播散的血管母细胞瘤作为晚期复发。
一名 65 岁的白人男性,1997 年曾行小脑蚓部世界卫生组织分级 I 级血管母细胞瘤全切除。2018 年初,他出现颅内复发,整个脊柱弥漫性软脑膜疾病。患者接受了颅内复发切除术,随后进行了姑息性颅脊髓照射。疾病进展迅速,复发后 8 个月死亡。
尽管病理学为良性,但血管母细胞瘤有低度转移风险。发生转移的血管母细胞瘤患者预后较差。对转移性血管母细胞瘤患者进行多学科治疗值得进一步研究,迫切需要有效的全身治疗选择。建议对高危患者进行终身定期随访。